Suez Canal University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Ismailia Egypt (1974)

Organization Overview

First Clinical Trial
2012
NCT01997203
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Amir Safwat | Anesthesia and Intesive Care department, Faculty of Medicine, Suez Canal University | Anesthesia Department, Faculty of Medicine, Suez Canal University | faculty of dentistry suez canal university | Faculty of dentistry , Suez canal university , Ismailia , Egypt | Faculty of Medicine, Suez-canal University | Family medicine Department, Faculty of Medicine, Suez Canal University, Egypt | Medical Biochemistry, faculty of Medicine Suez Canal University | Suez Canal University | Suez Canal University, Faculty of Medicine, Anesthesia and Intensive Care Department | Suez Canal University, Ismailia, Egypt | suez canal univesity

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 3)

Delayed Emergence from Anesthesia (Phase 4)

Emergence Delirium (Phase 4)

Fibromyalgia (Phase 1)

Heart Failure (Phase 4)

Hepatitis (Phase 3)

Hepatitis A (Phase 3)

Hepatitis C (Phase 3)

Hepatitis C, Chronic (Phase 3)

Hypotension (Phase 4)

Infertility (Phase 2)

Myofascial Pain Syndromes (Phase 1)

Psychomotor Agitation (Phase 4)

Vitiligo (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 24
  • # of Trial APIs: 28